Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$519M |
| 2 |
Netflix
NFLX
|
+$448M |
| 3 |
Qualcomm
QCOM
|
+$280M |
| 4 |
Microsoft
MSFT
|
+$252M |
| 5 |
Broadcom
AVGO
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$453M |
| 2 |
ExxonMobil
XOM
|
+$234M |
| 3 |
GMS
GMS Inc
GMS
|
+$217M |
| 4 |
SKX
Skechers
SKX
|
+$201M |
| 5 |
Capital One
COF
|
+$193M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 17.99% |
| 3 | Industrials | 12.15% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Healthcare | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DEA
2201
Easterly Government Properties
DEA
$1.17B
| $13M | ﹤0.01% |
565,526
+4,287
| +0.8% | +$97.4K |
|
2202
Relay Therapeutics
RLAY
$3.99B
| $13M | ﹤0.01% |
2,482,950
-306,510
| -11% | -$1.17M |
|
2203
Bowman Consulting
BWMN
$463M
| $12.9M | ﹤0.01% |
304,986
+24,760
| +9% | +$928K |
|
2204
AngioDynamics
ANGO
$593M
| $12.9M | ﹤0.01% |
1,155,666
-16,916
| -1% | -$163K |
|
2205
Coca-Cola Femsa
KOF
$22.8B
| $12.9M | ﹤0.01% |
154,903
+14,447
| +10% | +$1.25M |
|
2206
Vanda Pharmaceuticals
VNDA
$310M
| $12.8M | ﹤0.01% |
2,563,969
-21,788
| -0.8% | -$101K |
|
2207
ARKO Corp
ARKO
$901M
| $12.8M | ﹤0.01% |
2,798,778
+63,779
| +2% | +$301K |
|
2208
NLI Holdings
NL
$291M
| $12.8M | ﹤0.01% |
2,079,505
+3,316
| +0.2% | +$21K |
|
2209
MetroCity Bankshares
MCBS
$1.03B
| $12.8M | ﹤0.01% |
460,670
+9,931
| +2% | +$288K |
|
|
ZIMV
2210
DELISTED
ZimVie
ZIMV
| $12.8M | ﹤0.01% |
673,443
-690,480
| -51% | -$11.7M |
|
2211
Telkom Indonesia
TLK
$14.2B
| $12.7M | ﹤0.01% |
675,236
+14,066
| +2% | +$260K |
|
2212
Primis Financial Corp
FRST
$398M
| $12.7M | ﹤0.01% |
1,208,580
-18,763
| -2% | -$209K |
|
2213
Kosmos Energy
KOS
$1.39B
| $12.6M | ﹤0.01% |
7,611,298
-2,388,987
| -24% | -$4.47M |
|
2214
Utah Medical Products
UTMD
$226M
| $12.6M | ﹤0.01% |
200,032
+2,566
| +1% | +$152K |
|
|
ALEX
2215
DELISTED
Alexander & Baldwin
ALEX
| $12.6M | ﹤0.01% |
691,267
+160,626
| +30% | +$2.95M |
|
2216
Sarepta Therapeutics
SRPT
$1.63B
| $12.6M | ﹤0.01% |
651,598
-152,290
| -19% | -$2.71M |
|
2217
Savers
SVV
$1.58B
| $12.5M | ﹤0.01% |
939,845
+473,054
| +101% | +$5.44M |
|
|
PLYM
2218
DELISTED
Plymouth Industrial REIT
PLYM
| $12.5M | ﹤0.01% |
557,650
-8,873
| -2% | -$163K |
|
2219
Brookfield Renewable
BEPC
$5.93B
| $12.4M | ﹤0.01% |
360,634
-511,321
| -59% | -$17.5M |
|
2220
Spok Holdings
SPOK
$227M
| $12.4M | ﹤0.01% |
719,050
+8,160
| +1% | +$145K |
|
2221
Luxfer Holdings
LXFR
$456M
| $12.4M | ﹤0.01% |
891,782
+33,074
| +4% | +$425K |
|
2222
Viking Therapeutics
VKTX
$3.93B
| $12.4M | ﹤0.01% |
471,259
+235,189
| +100% | +$7.02M |
|
2223
Dave & Buster's
PLAY
$361M
| $12.4M | ﹤0.01% |
680,936
-19,245
| -3% | -$506K |
|
2224
Pangaea Logistics
PANL
$493M
| $12.4M | ﹤0.01% |
2,432,754
+86,281
| +4% | +$446K |
|
2225
C&F Financial
CFFI
$271M
| $12.3M | ﹤0.01% |
183,531
-1,281
| -0.7% | -$87K |
|
Similar funds
Dimensional Fund Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Dimensional Fund Advisors held 3,356 positions worth $466B, up 7.9% from $432B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q3 2025 filing shows 84 new, 1,582 increased, 1,511 reduced and 85 closed positions. Its largest new stake was Qiagen: 1,300,037 shares worth $58.1M. The largest sale was Hess, an estimated $453M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q3 2025 buy was Qiagen: 1,300,037 shares worth $58.1M.
- Dimensional Fund Advisors added most to Chevron in Q3 2025, an estimated $519M increase.
- Dimensional Fund Advisors's biggest Q3 2025 reduction was ExxonMobil, cutting an estimated $234M.
- Dimensional Fund Advisors fully exited Hess in Q3 2025, selling an estimated $453M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $466B portfolio in Q3 2025.
- Dimensional Fund Advisors opened 84 new positions and closed 85 in Q3 2025.
- Dimensional Fund Advisors's portfolio value rose 7.9% quarter-over-quarter to $466B.
Based on Dimensional Fund Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.